Unlock instant, AI-driven research and patent intelligence for your innovation.

Pharmaceutical composition containing phenyl pyrimidone hydrochloride, pharmaceutical preparation containing pharmaceutical composition, and preparation method and application of pharmaceutical composition

A technology of phenylpyrimidinone hydrochloride and pharmaceutical preparations, which is applied in the field of medicine, can solve the problems of slow dissolution of finished preparations, and achieve the effects of rapid disintegration, rapid dissolution, and good uniformity

Pending Publication Date: 2022-04-15
SUZHOU VIGONVITA LIFE SCIENCES CO LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] However, in the preparation of phenylpyrimidone compounds, because the proportion of phenylpyrimidone compounds is relatively small, the problem of mixing uniformity is prone to occur during the preparation process, and the finished preparation is prone to problems such as slow dissolution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing phenyl pyrimidone hydrochloride, pharmaceutical preparation containing pharmaceutical composition, and preparation method and application of pharmaceutical composition
  • Pharmaceutical composition containing phenyl pyrimidone hydrochloride, pharmaceutical preparation containing pharmaceutical composition, and preparation method and application of pharmaceutical composition
  • Pharmaceutical composition containing phenyl pyrimidone hydrochloride, pharmaceutical preparation containing pharmaceutical composition, and preparation method and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0059] [Preparation method of pharmaceutical composition]

[0060] The present invention provides a preparation method of the above pharmaceutical composition, which comprises the following steps: mixing the compound of formula I-A and a pharmaceutically acceptable carrier.

[0061] [pharmaceutical preparations]

[0062] The present invention provides a pharmaceutical preparation made from the above pharmaceutical composition.

[0063] In one embodiment, the pharmaceutical preparation is tablet, capsule, granule, pill, powder or dry suspension.

[0064] In a preferred embodiment, the pharmaceutical preparation is a tablet or a capsule.

[0065] [Preparation method of pharmaceutical preparation]

[0066] The present invention provides the preparation method of the above-mentioned pharmaceutical preparation, which can choose the preparation method of direct mixing, wet granulation or dry granulation, preferably the preparation method of direct mixing.

[0067] Described prep...

Embodiment 1

[0089] Example 1: Tablet formulation (direct compression)

[0090]

[0091] Preparation Process:

[0092] (1) Material pretreatment: the compound of formula I-A is pulverized, and the particle size D is measured 90 =18.8 μm; the auxiliary materials are passed through an 80-mesh sieve for later use.

[0093] (2) Weighing: Weigh the compound of formula I-A, lactose, microcrystalline cellulose, sodium carboxymethyl starch, povidone, and magnesium stearate according to the prescription amount.

[0094] (3) Mixing: Add other ingredients except magnesium stearate into a hopper mixer, and mix for 10 minutes at a rotating speed of 10 rpm / min.

[0095](4) Lubrication: Add magnesium stearate, set the rotating speed at 10rpm / min, and mix for 5 minutes to obtain a total blended powder; sample 10 points at different positions of the mixer to measure the mixing uniformity. Determine the particle content and calculate the tablet weight.

[0096] (5) Tablet compression: Rotary tablet p...

Embodiment 2

[0098] Example 2: Tablet formulation (wet granulation)

[0099]

[0100] Preparation Process:

[0101] (1) Material pretreatment: the compound of formula I-A is pulverized, and the particle size D is measured 90 =18.8 μm; the auxiliary materials are passed through an 80-mesh sieve for later use.

[0102] (2) Weighing: Weigh the compound of formula I-A, lactose, microcrystalline cellulose, sodium carboxymethyl starch, povidone, and magnesium stearate according to the prescription amount.

[0103] (3) Adhesive solution preparation: add the prescribed amount of povidone K30 into 50% ethanol solution, stir continuously, and prepare a clear 5% (w / w) povidone ethanol solution for later use.

[0104] (3) Pre-mixing: Add other ingredients except magnesium stearate into a high-speed wet granulator, stir at a speed of 180 rpm / min, and mix for 10 minutes.

[0105] (4) Granulation: set the stirring speed at 180rpm / min, the shearing speed at 1200rpm / min, add the binder solution for g...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a pharmaceutical composition containing phenyl pyrimidone hydrochloride, a pharmaceutical preparation containing the pharmaceutical composition, and a preparation method and application of the pharmaceutical composition. Specifically, the pharmaceutical composition provided by the invention comprises a compound as shown in a formula I-A and a pharmaceutically acceptable carrier. The problems of low mixing uniformity, low content uniformity and low dissolution speed are solved by limiting the particle size of the compound shown in the formula I-A, screening the composition and dosage of auxiliary materials and researching the preparation process. The pharmaceutical composition or the pharmaceutical preparation is good in content uniformity, good in stability, rapid in disintegration and capable of achieving rapid dissolution, can be prepared through a direct mixing technology or a wet granulation technology, preferentially uses the direct mixing technology, and has the advantages of being simple in prescription technology, low in cost, capable of saving energy, environmentally friendly, easy to industrially apply and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a pharmaceutical composition containing phenylpyrimidinone hydrochloride, a pharmaceutical preparation containing it, and a preparation method thereof, and also relates to the application of the pharmaceutical composition or pharmaceutical preparation in medicine. Background technique [0002] Erectile dysfunction (Erectile Dysfunction, ED), commonly known as "impotence", refers to the persistent inability of a man to achieve or maintain a penile erection with sufficient hardness to complete a satisfactory sexual life under sexual stimulation. The diagnosis is ED. According to epidemiological data (J Androl,2011,32:496). [0003] In the drug treatment of ED, phosphodiesterase 5 (Phosphodiesterase 5, PDE5) inhibitors are convenient to use, safe, effective, and easily accepted by most patients, and are currently the first choice in clinical practice. The currently app...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/513A61K9/20A61K9/48A61K47/38A61K47/36A61K47/32A61K47/26A61P15/10A61P9/10A61P9/12A61P9/04A61P11/00A61P13/12A61P11/06A61P11/02A61P27/06A61P37/08
Inventor 杨汝磊吴凤英田广辉
Owner SUZHOU VIGONVITA LIFE SCIENCES CO LTD